Hudson Bay Capital Management LP Biotech Acquisition CO Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	BUY	$8.96 - $9.97 $6.74 Million - $7.5 Million	751,824 Added 147.48%	1,261,609 $12.5 Million
Q1 2022 May 16, 2022	BUY	$9.75 - $9.91 $177,050 - $179,955	18,159 Added 3.69%	509,785 $5.02 Million
Q4 2021 Feb 14, 2022	BUY	$9.73 - $9.91 $989,502 - $1.01 Million	101,696 Added 26.08%	491,626 $4.84 Million
Q2 2021 Aug 16, 2021	BUY	$9.64 - $9.88 $1.83 Million - $1.88 Million	189,930 Added 94.97%	389,930 $3.77 Million
Q1 2021 May 14, 2021	BUY	$9.56 - $9.73 $1.91 Million - $1.95 Million	200,000 New	200,000 $1.94 Million

Others Institutions Holding BIOT

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Biotech Acquisition Co

Ticker BIOT
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 23,000,000
Description
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

More about BIOT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.